COHEN RON 4
4 · Acorda Therapeutics, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
COHEN RON
President and CEO
Transactions
- Purchase
Common Stock
2023-03-16$0.60/sh+10,156$6,094→ 139,757 total - Purchase
Common Stock
2023-03-17$0.65/sh+10,000$6,500→ 149,757 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.590 to $0.600. The reporting person undertakes to provide to Acorda Therapeutics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.